Nicole Kallewaard
Affiliations: | University of Pennsylvania, Philadelphia, PA, United States |
Google:
"Nicole Kallewaard"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Loo YM, McTamney PM, Arends RH, et al. (2022) The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in non-human primates and has an extended half-life in humans. Science Translational Medicine. eabl8124 |
| Kinder JT, Moncman CL, Barrett C, et al. (2020) Respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) infections in 3-D human airway tissues expose an interesting dichotomy in viral replication, spread, and inhibition by neutralizing antibodies. Journal of Virology |
| Zost SJ, Gilchuk P, Case JB, et al. (2020) Potently neutralizing and protective human antibodies against SARS-CoV-2. Nature |
| Zost SJ, Gilchuk P, Case JB, et al. (2020) Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals. Biorxiv : the Preprint Server For Biology |
| Robinson KM, Ramanan K, Tobin JM, et al. (2019) Survival during influenza-associated bacterial superinfection improves following viral- and bacterial-specific monoclonal antibody treatment. Jci Insight. 4 |
| Ali SO, Takas T, Nyborg A, et al. (2018) Evaluation of MEDI8852, an Anti-Influenza A Monoclonal Antibody, in Treating Acute Uncomplicated Influenza. Antimicrobial Agents and Chemotherapy |
| Zhu Q, Lu B, McTamney P, et al. (2018) Prevalence and significance of substitutions in the fusion protein of respiratory syncytial virus resulting in neutralization escape from antibody MEDI8897. The Journal of Infectious Diseases |
| Elliott STC, Kallewaard NL, Benjamin E, et al. (2017) DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections. Npj Vaccines. 2: 18 |
| Paules CI, Lakdawala S, McAuliffe JM, et al. (2017) An HA stem antibody MEDI8852 prevents and controls disease and limits transmission of pandemic influenza viruses. The Journal of Infectious Diseases |
| Corti D, Cameroni E, Guarino B, et al. (2017) Tackling influenza with broadly neutralizing antibodies. Current Opinion in Virology. 24: 60-69 |